Takeda's ADZYNMA® Receives Approval in Japan for Congenital Thrombotic Thrombocytopenic Purpura (cTTP)

    cTTP, an ultra-rare blood clotting disorder, presents life-threatening acute events and debilitating chronic symptoms. Untreated acute TTP ...

March 27, 2024 | Wednesday | News
MediciNova Receives Notice of Allowance for MN-166 Patent in Japan

MediciNova, Inc., a biopharmaceutical company listed on the NASDAQ Global Market (NASDAQ:MNOV) and the Tokyo Stock Exchange (Code Number: 4875), has receiv...

March 27, 2024 | Wednesday | News
Orchard Therapeutics Achieves Landmark FDA Approval for Lenmeldy™, Pioneering Gene Therapy for Early-onset Metachromatic Leukodystrophy

Orchard Therapeutics, now under the stewardship of Kyowa Kirin, announces a historic milestone as the U.S. Food and Drug Administration (FDA) grants approv...

March 19, 2024 | Tuesday | News
Beckman Coulter and Fujirebio to Develop Blood-based Neurodegenerative Disease Diagnostics

  In 2023, Beckman Coulter and Fujirebio entered into a collaboration agreement focused on new biomarkers aligned with recently approved monoclonal a...

March 13, 2024 | Wednesday | News
Daiichi Sankyo and AstraZeneca's Datopotamab Deruxtecan BLA Accepted in U.S. for Advanced Nonsquamous NSCLC Treatment

Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE/STO/Nasdaq: AZN) have announced the acceptance of their Biologics License Application (BLA) for datopotamab...

February 19, 2024 | Monday | News
Japan first in the world to approve Dupixent® for chronic spontaneous urticaria (CSU)

  Approval based primarily on results from Phase 3 trial showing Dupixent significantly reduced itch compared to placebo CSU is the fifth approved...

February 16, 2024 | Friday | News
Ajinomoto Co. Expands Presence in Silicon Valley with Launch of Corporate Venture Capital Headquarters

The expansion into Silicon Valley marks a strategic move for Ajinomoto Co., which seeks to support and collaborate with innovators across four key growth a...

February 13, 2024 | Tuesday | News
Takeda Advances Global Phase 3 Trials of TAK-861 in Narcolepsy Type 1 Following Positive Phase 2b Results

Takeda  unveiled promising topline results from a comprehensive Phase 2b trial evaluating TAK-861, an oral orexin receptor 2 (OX2R) agonist, in patien...

February 12, 2024 | Monday | News
Nikon Expands Global BioImaging Network with New Labs in USA and Japan

Nikon Instruments Inc. (Nikon) is pleased to announce the establishment of the Nikon BioImaging Lab Lexington in Massachusetts, USA, where it will provide ...

January 29, 2024 | Monday | News
Travere Licenses Sparsentan to Renalys Pharma for Japan, South Korea, Taiwan, and Southeast Asia

Travere Therapeutics, Inc. announced that it has entered into an exclusive licensing agreement with Renalys Pharma, Inc., to bring sparsentan, a dual endot...

January 26, 2024 | Friday | News
Fujirebio and Agappe Ink CLIA Immunoassay Collaboration Agreement

In a significant move, Agappe and Fujirebio have revealed plans to launch these products in June 2024. The project has already achieved significant progres...

January 19, 2024 | Friday | News
SyntheticGestalt, Enamine Partner for AI-Driven Drug Discovery Model

SyntheticGestalt, a research and development company specializing in the application of AI to the life sciences domain, and Enamine, the world's leading pr...

January 15, 2024 | Monday | News
Elpiscience, Astellas Partner on Bispecific Macrophage Engager

The two companies will collaboratively conduct early-stage research for these two programs. Elpiscience will also grant Astellas the right to add up to two...

December 28, 2023 | Thursday | News
JCR and Alexion Partner on Oligonucleotide Therapeutics Using J-Brain Cargo® Technology

-JCR Pharmaceuticals Co., Ltd. (TSE 4552; Chairman and President: Shin Ashida: “JCR”) announces that it has signed a Research Collaboration, Op...

December 22, 2023 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in